Volitionrx Stock Return On Asset

VNRX Stock  USD 0.69  0.01  1.43%   
Volitionrx fundamentals help investors to digest information that contributes to Volitionrx's financial success or failures. It also enables traders to predict the movement of Volitionrx Stock. The fundamental analysis module provides a way to measure Volitionrx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Volitionrx stock.
Return On Assets is likely to drop to -1.33 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Volitionrx Company Return On Asset Analysis

Volitionrx's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Volitionrx Return On Asset

    
  -1.01  
Most of Volitionrx's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Volitionrx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Volitionrx Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Volitionrx is extremely important. It helps to project a fair market value of Volitionrx Stock properly, considering its historical fundamentals such as Return On Asset. Since Volitionrx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Volitionrx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Volitionrx's interrelated accounts and indicators.
0.3-0.94-0.850.640.680.990.88-0.890.920.810.440.510.9-0.610.810.86-0.17-0.270.670.52
0.3-0.510.19-0.48-0.490.36-0.17-0.110.03-0.20.99-0.65-0.07-0.65-0.020.240.80.77-0.38-0.62
-0.94-0.510.65-0.4-0.47-0.97-0.690.77-0.74-0.58-0.64-0.31-0.720.72-0.63-0.73-0.010.07-0.48-0.34
-0.850.190.65-0.92-0.92-0.8-0.990.89-0.96-0.990.05-0.79-0.990.25-0.92-0.820.510.62-0.91-0.77
0.64-0.48-0.4-0.920.950.570.91-0.740.810.91-0.370.890.880.00.770.58-0.7-0.790.90.85
0.68-0.49-0.47-0.920.950.630.93-0.720.810.89-0.350.970.87-0.060.760.6-0.77-0.840.90.96
0.990.36-0.97-0.80.570.630.83-0.860.870.750.50.470.85-0.650.760.83-0.13-0.220.620.49
0.88-0.17-0.69-0.990.910.930.83-0.890.950.96-0.030.810.98-0.30.890.81-0.51-0.620.880.81
-0.89-0.110.770.89-0.74-0.72-0.86-0.89-0.91-0.86-0.24-0.56-0.90.55-0.84-0.850.290.39-0.7-0.55
0.920.03-0.74-0.960.810.810.870.95-0.910.950.170.650.98-0.40.930.9-0.33-0.440.80.64
0.81-0.2-0.58-0.990.910.890.750.96-0.860.95-0.070.750.98-0.190.930.83-0.47-0.580.870.73
0.440.99-0.640.05-0.37-0.350.5-0.03-0.240.17-0.07-0.520.07-0.710.090.350.720.69-0.26-0.48
0.51-0.65-0.31-0.790.890.970.470.81-0.560.650.75-0.520.720.050.590.41-0.88-0.930.840.99
0.9-0.07-0.72-0.990.880.870.850.98-0.90.980.980.070.72-0.330.920.85-0.41-0.520.860.71
-0.61-0.650.720.250.0-0.06-0.65-0.30.55-0.4-0.19-0.710.05-0.33-0.25-0.49-0.16-0.140.030.04
0.81-0.02-0.63-0.920.770.760.760.89-0.840.930.930.090.590.92-0.250.93-0.29-0.40.840.58
0.860.24-0.73-0.820.580.60.830.81-0.850.90.830.350.410.85-0.490.93-0.11-0.20.630.4
-0.170.8-0.010.51-0.7-0.77-0.13-0.510.29-0.33-0.470.72-0.88-0.41-0.16-0.29-0.110.99-0.6-0.85
-0.270.770.070.62-0.79-0.84-0.22-0.620.39-0.44-0.580.69-0.93-0.52-0.14-0.4-0.20.99-0.7-0.89
0.67-0.38-0.48-0.910.90.90.620.88-0.70.80.87-0.260.840.860.030.840.63-0.6-0.70.83
0.52-0.62-0.34-0.770.850.960.490.81-0.550.640.73-0.480.990.710.040.580.4-0.85-0.890.83
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Volitionrx Total Assets

Total Assets

29.35 Million

At this time, Volitionrx's Total Assets are fairly stable compared to the past year.
Based on the latest financial disclosure, Volitionrx has a Return On Asset of -1.0082. This is 88.48% lower than that of the Health Care Equipment & Supplies sector and 86.61% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Volitionrx Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Volitionrx's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Volitionrx could also be used in its relative valuation, which is a method of valuing Volitionrx by comparing valuation metrics of similar companies.
Volitionrx is currently under evaluation in return on asset category among its peers.

Volitionrx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Volitionrx from analyzing Volitionrx's financial statements. These drivers represent accounts that assess Volitionrx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Volitionrx's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap185.7M176.1M165.3M134.5M51.1M75.8M
Enterprise Value172.7M161.1M148.8M128.6M36.2M68.4M

Volitionrx Fundamentals

About Volitionrx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Volitionrx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Volitionrx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Volitionrx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.